Bicycle Therapeutics plc

NASDAQ:BCYC

Biotechnology

Healthcare
$3.20 -1.36%

-$0.06 today

Market cap
$224.30M
Beta
1.54
P/E (TTM)
-1.3
EPS (TTM)
-$3.14
52W Low $3.95High $9.18

Volume 0.45M

Average 0.49M

Returns on capital

Bicycle Therapeutics plc management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-35.9%

avg -35.6%

ROIC

-40.7%

avg -43.0%

ROA

-30.5%

avg -34.2%

Analysis

ROA is currently the strongest return metric at -30.5% versus its period average of -34.2%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Kevin Lee

Chief Executive Officer & Executive DirectorUSD 1.66M58595.87K0.86%

Michael Skynner

Chief Scientific OfficerUSD 1M57154.73K0.22%

Alistair Milnes

Chief Corporate Development OfficerUSD 965.95K52136.72K0.20%

Travis Thompson

Chief Financial OfficerUSD 948.77K46——

Jennifer Perry

Chief Operating OfficerUSD 909.05K52——

Michael Charles-Ferguson Hannay

Chief Product & Supply Chain OfficerUSD 698.38K6092.56K0.13%

Christian Heinis

Scientific Founder————

Zafar Qadir

Chief Legal Officer & General Counsel————

Phil Jeffrey

Senior Vice President of Pre-Clinical Development————

Stephanie Yao

Senior Vice President of Investor Relations and Corporate Communications————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Oct 5, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

0

$0.00

Sells

49

$522,733.30

Net Transaction Value

−$522,733.30

Net selling

Most Active

Perry Jennifer Scott

11 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Oct 5, 26

Perry Jennifer Scott

Direct

Sell$1.2K
Oct 5, 26

Skynner Michael

Direct

Sell$1.8K
Oct 5, 26

Hannay Michael Charles Ferguson

Direct

Sell$863.9
Oct 5, 26

Perry Jennifer Scott

Direct

Sell$107.1
Oct 5, 26

Perry Jennifer Scott

Direct

Sell$284.8
Oct 5, 26

Perry Jennifer Scott

Direct

Sell$1.2K
Oct 5, 26

Lee Kevin

Direct

Sell$5.8K
Oct 5, 26

Thompson Travis Alvin

Direct

Sell$282
Oct 2, 26

Hannay Michael Charles Ferguson

Direct

Sell$5.5K
Oct 2, 26

Thompson Travis Alvin

Direct

Sell$3.1K

1–10 of 49

Summary

Insiders reported 0 buys worth $0.00 and 49 sells worth $522,733.30 over the last 12 months. That adds up to net selling of $522,733.30. Perry Jennifer Scott was the most active insider with 11 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A4 analysts
RevenueN/AN/A+71.2%
+12.4% (5yr)4 analysts
Net IncomeN/AN/AN/A
N/A4 analysts
EBITN/AN/AN/A
N/A4 analysts

Analysis

Recent growth has been strongest in Revenue at +71.2% over three years. Forward estimates point to Revenue at +12.4% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Bicycle Therapeutics plc compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about BCYC's management, answered from reported figures.

Who manages BCYC?

Bicycle Therapeutics plc (BCYC) lists 10 active executives. The top listed executive is Christian Heinis, Scientific Founder.

Are BCYC insiders buying or selling?

Recent insider activity shows net buying of $41.88M.